2023
An Update on Nondopaminergic Treatments for Motor and Non-motor Symptoms of Parkinson’s Disease
Jing XZ, Yuan XZ, Luo X, Zhang SY, Wang XP. An Update on Nondopaminergic Treatments for Motor and Non-motor Symptoms of Parkinson’s Disease. Current Neuropharmacology 2023, 21: 1806-1826. PMID: 35193486, PMCID: PMC10514518, DOI: 10.2174/1570159x20666220222150811.Peer-Reviewed Original ResearchConceptsNon-motor symptomsDopamine replacement therapyPD patientsMotor fluctuationsParkinson's diseaseNondopaminergic treatmentsReplacement therapyCertain non-motor symptomsTraditional dopamine replacement therapyLower urinary tract symptomsUrinary tract symptomsOngoing clinical trialsPotential adverse eventsManagement of motorPositive clinical implicationsManagement of hallucinationsDopaminergic strategiesMotor complicationsNondopaminergic drugsPD psychosisOrthostatic hypotensionTract symptomsAdverse eventsClinical benefitClinical efficacy
2021
Comparison of the clinical efficacy of penicillin and ceftriaxone sodium in the treatment of neurosyphilis with psychiatric symptoms.
Wang S, Gu W, Cao Y, Zheng H, Zhang L, Guo X, Chen W, Luo X. Comparison of the clinical efficacy of penicillin and ceftriaxone sodium in the treatment of neurosyphilis with psychiatric symptoms. World Journal Of Psychiatry And Mental Health Research 2021, 5 PMID: 35005746, PMCID: PMC8740858.Peer-Reviewed Original ResearchMini-Mental State ExaminationCognitive functionBrief Psychiatric Rating ScalePsychiatric symptomsTreatment of neurosyphilisMental symptomsClinical efficacySymptoms patientsPenicillin groupState ExaminationLife abilityPsychiatric Rating ScaleCeftriaxone sodiumMain time effectMMSE scoresTotal treatment timeRating ScaleSodium groupTreatment groupsNeurosyphilisSymptomsMeasurement of efficiencyPenicillinSignificant differencesPatients